- Shares of RTI Surgical (RTIX) are poised for a gap up at the open. Investors appear to like the prospects of two new products launched today.
- NanOss Bioactive 3D, a synthetic three dimensional bioscaffold that supports bone formation and map3 Cellular Allogeneic Bone Graft, an implant that generates and maintains new bone are now available for commercial sale.
- Consensus EPS and revenue estimates for 2014 and 2015 are $0.07/share on revenues of $237M and $0.13/share on revenues of $268M, respectively.
- 162 mutual funds have positions, down from 197 a year earlier.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs